Carina A. Dehner

Carina A. Dehner

Auto-generated profile, based on publicly available information

Carina A. Dehner

Department of Pathology and Laboratory Medicine Hospital of the University of Pennsylvania Philadelphia PA USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2018 in Science
Verified
Journal Article
Closed access
PDF file
SVS. Manfredo Vieira
S. Manfredo Vieira
MHM. Hiltensperger
M. Hiltensperger
VKV. Kumar
V. Kumar
DRDaniel Zegarra Ruiz
Daniel Zegarra Ruiz
CDC. Dehner
C. Dehner
MKM. A. Kriegel
M. A. Kriegel
Bacterial involvement in autoimmunity: The composition of the commensal microbiota is known to influence autoimmune disease development and persistence. Manfredo Vieira et al. identified a gut microbe, Enterococcus gallinarum , that translocates from the gut into the organs of mice with a genetic predisposition to lupus-like autoimmunity (see the Perspective by Citi). Molecular signatures of gut barrier disintegration and pathogenic T helper cells were evident in the gut, liver, and lymphoid organs during colonization with the pathobiont. The ensuing pathology could be reversed by vancomycin treatment and by vaccination against E. gallinarum . The same bug was also found in liver biopsies of autoimmune patients, but not in healthy controls. Science , this issue p. 1156 ; see also p. 1097

28 March 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
TGTeri Greiling
Teri Greiling
CDCarina Dehner
Carina Dehner
XCXinguo Chen
Xinguo Chen
KHKevin Hughes
Kevin Hughes
AIAlonso J. Iñiguez
Alonso J. Iñiguez
MKMartin A. Kriegel
Martin A. Kriegel
Commensal bacterial orthologs of the human autoantigen Ro60 may trigger cross-reactive T and B cells that initiate and sustain chronic autoimmunity in lupus.

26 January 2024 in Human Pathology
Verified
Journal Article
Open access
CDCarina A. Dehner
Carina A. Dehner
ALAlexander J. Lazar
Alexander J. Lazar
JCJohn S.A. Chrisinger
John S.A. Chrisinger
The WHO Classification of Soft Tissue and Bone Tumors currently recognizes four categories of undifferentiated small round cell sarcoma: Ewing sarcoma, round cell sarcoma with EWSR1-non-ETS fusions including NFATc2 and PATZ1, CIC-rearranged sarcoma, and sarcoma with BCOR genetic alterations. These neoplasms frequently pose significant diagnostic challenges due to rarity and overlapping morphologic and immunohistochemical findings. Further, molecular testing, with accompanying pitfalls, may be needed to establish a definitive diagnosis. This review summarizes the clinical, histologic, immunohistochemical, and molecular features of these neoplasms. In addition, differential diagnosis and areas of uncertainty and ongoing investigation are discussed.

21 December 2023 in Human Pathology
Verified
Journal Article
Closed access
CDCarina A. Dehner
Carina A. Dehner
ERErin R. Rudzinski
Erin R. Rudzinski
JDJessica L. Davis
Jessica L. Davis

8 November 2024 in Laboratory Investigation
Verified
Journal Article
Closed access
CDCarina A. Dehner
Carina A. Dehner
LWLaura M. Warmke
Laura M. Warmke
BUBrandon Umphress
Brandon Umphress
FMFaizan Malik
Faizan Malik
JCJeffrey M. Cloutier
Jeffrey M. Cloutier
AFAndrew L. Folpe
Andrew L. Folpe

2 August 2024 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
RSRussell Taylor Sundby
Russell Taylor Sundby
JSJeffrey J. Szymanski
Jeffrey J. Szymanski
APAlexander C. Pan
Alexander C. Pan
PJPaul A. Jones
Paul A. Jones
SMSana Z. Mahmood
Sana Z. Mahmood
JSJack F Shern
Jack F Shern
Purpose: Early detection of neurofibromatosis type 1 (NF1)–associated peripheral nerve sheath tumors (PNST) informs clinical decision-making, enabling early definitive treatment and potentially averting deadly outcomes. In this study, we describe a cell-free DNA (cfDNA) fragmentomic approach that distinguishes nonmalignant, premalignant, and malignant forms of PNST in the cancer predisposition syndrome, NF1. Experimental Design: cfDNA was isolated from plasma samples of a novel cohort of 101 patients with NF1 and 21 healthy controls and underwent whole-genome sequencing. We investigated diagnosis-specific signatures of copy-number alterations with in silico size selection as well as fragment profiles. Fragmentomics were analyzed using complementary feature types: bin-wise fragment size ratios, end motifs, and fragment non-negative matrix factorization signatures. Results: The novel cohort of patients with NF1 validated that our previous cfDNA copy-number alteration–based approach identifies malignant PNST (MPNST) but cannot distinguish between benign and premalignant states. Fragmentomic methods were able to differentiate premalignant states including atypical neurofibromas (AN). Fragmentomics also adjudicated AN cases suspicious for MPNST, correctly diagnosing samples noninvasively, which could have informed clinical management. Conclusions: Novel cfDNA fragmentomic signatures distinguish AN from benign plexiform neurofibromas and MPNST, enabling more precise clinical diagnosis and management. This study pioneers the early detection of malignant and premalignant PNST in NF1 and provides a blueprint for decentralizing noninvasive cancer surveillance in hereditary cancer predisposition syndromes.